CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2 Study of Sunitinib Malate in Recurrent or Metastatic Endometrial Carcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00478426
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:24.313430+00:00
Published At: 2020-02-17T00:00:00+00:00
Record Updated At: 2020-02-17
Results Posted At: 2020-02-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Endometrial Adenocarcinoma", "Endometrial Endometrioid Adenocarcinoma", "Endometrial Serous Adenocarcinoma", "Recurrent Uterine Corpus Carcinoma", "Stage IVA Uterine Corpus Cancer AJCC v7", "Stage IVB Uterine Corpus Cancer AJCC v7", "Uterine Carcinosarcoma", "Uterine Corpus Carcinosarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-02-17"
protocolSection.identificationModule.nctId: "NCT00478426"
protocolSection.identificationModule.officialTitle: "A Phase 2 Study of Sunitinib Malate in Recurrent or Metastatic Endometrial Carcinoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2020-02-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.